We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+6.77%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
-$18.3M
(-0.06%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-5.69%
Top 10 Holdings %
Top 10 Hldgs %
43.66%
Holding
291
New
10
Increased
60
Reduced
140
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$45.6M |
| 2 |
AstraZeneca
AZN
|
+$37.9M |
| 3 |
EOG Resources
EOG
|
+$23.4M |
| 4 |
UnitedHealth
UNH
|
+$20.1M |
| 5 |
Eli Lilly
LLY
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$152M |
| 2 |
Procter & Gamble
PG
|
+$129M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$128M |
| 4 |
Apple
AAPL
|
+$123M |
| 5 |
Chevron
CVX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.27% |
| 2 | Financials | 17.16% |
| 3 | Consumer Staples | 16.61% |
| 4 | Energy | 11.67% |
| 5 | Healthcare | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.97T
| $2.96B | 10.36% |
15,248,555
-707,192
| -4% | -$123M |
|
|
2
Microsoft
MSFT
$2.9T
| $2.32B | 8.12% |
6,809,669
-485,721
| -7% | -$152M |
|
3
Philip Morris
PM
$309B
| $1.2B | 4.2% |
12,290,227
-870,518
| -7% | -$83.2M |
|
4
Coca-Cola
KO
$383B
| $1.12B | 3.92% |
18,608,486
-878,048
| -5% | -$54.6M |
|
5
ExxonMobil
XOM
$650B
| $1.06B | 3.72% |
9,891,942
-657,588
| -6% | -$71.7M |
|
6
T. Rowe Price
TROW
$25.5B
| $839M | 2.94% |
7,491,415
-72,125
| -1% | -$7.9M |
|
|
NVO
7
Novo Nordisk
NVO
$228B
| $829M | 2.9% |
10,239,370
-321,344
| -3% | -$26.3M |
|
|
8
Chevron
CVX
$382B
| $804M | 2.81% |
5,108,005
-695,712
| -12% | -$112M |
|
9
Amazon
AMZN
$2.44T
| $680M | 2.38% |
5,214,348
+18,632
| +0.4% | +$2.13M |
|
10
Alphabet (Google) Class C
GOOG
$4.11T
| $658M | 2.3% |
5,439,144
-155,509
| -3% | -$18M |
|
11
McDonald's
MCD
$193B
| $630M | 2.21% |
2,110,847
-55,570
| -3% | -$16.1M |
|
12
Visa
V
$701B
| $628M | 2.2% |
2,642,563
-23,284
| -0.9% | -$5.33M |
|
13
JPMorgan Chase
JPM
$916B
| $619M | 2.17% |
4,255,147
-429,701
| -9% | -$59.1M |
|
14
Texas Instruments
TXN
$248B
| $600M | 2.1% |
3,331,024
-35,955
| -1% | -$6.19M |
|
|
HES
15
DELISTED
Hess
HES
| $571M | 2% |
4,202,815
-156,708
| -4% | -$21.4M |
|
16
PepsiCo
PEP
$196B
| $545M | 1.91% |
2,944,060
-28,394
| -1% | -$5.3M |
|
17
S&P Global
SPGI
$124B
| $544M | 1.9% |
1,356,766
-13,895
| -1% | -$5.08M |
|
|
18
UnitedHealth
UNH
$382B
| $536M | 1.88% |
1,115,478
+41,087
| +4% | +$20.1M |
|
|
19
Procter & Gamble
PG
$340B
| $524M | 1.84% |
3,453,313
-855,960
| -20% | -$129M |
|
20
Union Pacific
UNP
$174B
| $483M | 1.69% |
2,359,951
-63,055
| -3% | -$12.5M |
|
21
Altria Group
MO
$125B
| $439M | 1.54% |
9,697,591
-1,822,315
| -16% | -$82.5M |
|
22
Enterprise Products Partners
EPD
$83.7B
| $438M | 1.53% |
16,631,863
+62,558
| +0.4% | +$1.64M |
|
23
Air Products & Chemicals
APD
$65.5B
| $435M | 1.52% |
1,451,334
-13,181
| -0.9% | -$3.75M |
|
24
Abbott
ABT
$188B
| $429M | 1.5% |
3,931,137
-148,160
| -4% | -$15.8M |
|
25
Blackrock
BLK
$167B
| $400M | 1.4% |
579,424
+10,738
| +2% | +$7.19M |
|
Similar funds
HF
Fayez Sarofim & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, down 0.06% from $28.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Fayez Sarofim & Co withdrew a net $1.63B in Q2 2023, closing 13 positions and reducing 140 holdings. Its most notable exit was AvalonBay Communities, an estimated $1.33M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Fayez Sarofim & Co opened a new position in iShares Core High Dividend ETF worth $8.67M.
- Fayez Sarofim & Co's largest Q2 2023 buy was iShares Core High Dividend ETF: 430,000 shares worth $8.67M.
- Fayez Sarofim & Co added most to CME Group in Q2 2023, an estimated $45.6M increase.
- Fayez Sarofim & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $152M.
- Fayez Sarofim & Co fully exited AvalonBay Communities in Q2 2023, selling an estimated $1.33M.
- Fayez Sarofim & Co's ten largest holdings make up 44% of its $28.6B portfolio in Q2 2023.
- Fayez Sarofim & Co opened 10 new positions and closed 13 in Q2 2023.
- Fayez Sarofim & Co's portfolio value fell 0.06% quarter-over-quarter to $28.6B.
Based on Fayez Sarofim & Co's 13F filing for Q2 2023, filed 14 Aug 2023.